Delivery Order SPE2DB20D2104-SPE2DB22FT84Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,759.04 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price structure and a completion date of September 12, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,177.10 delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of March 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,464.08 Firm Fixed Price Delivery Order is for the supply of 0.75 mg/0.5 ml Trulicity Pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $3,004.24 firm-fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract has an ultimate completion date of June 22, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $3,526.04 firm fixed-price contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, solicited by the Defense Logistics Agency (DLA), was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,738.42 firm fixed-price delivery order covers the procurement of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,741.68 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
- This federal contract award, valued at $8,708.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of August 18, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,652.76 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. There is no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,562.80 Firm Fixed Price Delivery Order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT84ZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,026.56 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract is a firm-fixed-price delivery order with a completion date of September 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/7/22 |